Six Economic Development Leaders Unite to Position Hays-Caldwell Corridor as Texas’s Next Growth Engine

Six Economic Development Leaders Unite to Position Hays-Caldwell Corridor as Texas’s Next Growth Engine

A record gathering of six economic development leaders in Buda signals a coordinated push to attract investment across five communities in the Austin-San Antonio Innovation Corridor.

September 10, 2026Read the full article →
Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction

Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction

Earth Science Tech Inc. reported fiscal 2026 revenue of $35.7 million, up from $33.1 million in fiscal 2025, while eliminating long-term debt and improving its balance sheet.

September 10, 2026Read the full article →
Silver Bow Mining Secures Court Approval and Initial Closing for Montana Metallurgical Complex

Silver Bow Mining Secures Court Approval and Initial Closing for Montana Metallurgical Complex

Silver Bow Mining Corp. has received bankruptcy court approval and completed an initial closing to acquire the Jefferson County Metallurgical Complex, a move that could expand its critical minerals po...

September 10, 2026Read the full article →
SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program, Reports Strong Q2 Growth

SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program, Reports Strong Q2 Growth

SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program using its SSi Mantra 3.0 system, a milestone that highlights the company's expanding global footprint and ra...

September 10, 2026Read the full article →
Extend your brand profile by curating daily news.
SKYX Platforms to Merge with Deako, Creating Smart Home and AI Powerhouse

SKYX Platforms to Merge with Deako, Creating Smart Home and AI Powerhouse

SKYX Platforms' merger with Deako combines plug-and-play technologies to accelerate smart home adoption and generate recurring revenue, with significant implications for the building industry.

September 10, 2026Read the full article →
Perpetuals.com and European Institute of Management Launch Joint AI Trading Research Group

Perpetuals.com and European Institute of Management Launch Joint AI Trading Research Group

Perpetuals.com and the European Institute of Management have launched a joint research group to develop AI-powered trading models, a collaboration that could advance the use of machine learning and cr...

September 10, 2026Read the full article →
Global Industry Giants Forge Consensus on Near-Packaged Optics Standards to Accelerate Commercial Adoption

Global Industry Giants Forge Consensus on Near-Packaged Optics Standards to Accelerate Commercial Adoption

The NPO Standards Industry Summit in Shenzhen brought together global tech leaders to agree on international standards for near-packaged optics, a move set to drive energy-efficient data center interc...

September 10, 2026Read the full article →
Trilogy Metals Named to 2026 TSX30 After 570% Share Price Surge

Trilogy Metals Named to 2026 TSX30 After 570% Share Price Surge

Trilogy Metals Inc. has been recognized as one of the top performers on the Toronto Stock Exchange with a 570% share price increase, highlighting the strategic value of its Arctic Project to the U.S. ...

September 10, 2026Read the full article →
Wrap Technologies Expands Public Safety Platform with Training and Technology Integration

Wrap Technologies Expands Public Safety Platform with Training and Technology Integration

Wrap Technologies is broadening its public safety platform by integrating training, technology, and response capabilities, as demonstrated by its selection for Florida's Teacher Safety Training Progra...

September 10, 2026Read the full article →
Optimi Health Plans Phase 2 Psilocybin Trial for Major Depressive Disorder

Optimi Health Plans Phase 2 Psilocybin Trial for Major Depressive Disorder

Optimi Health Corp. will initiate a Health Canada-authorized Phase 2 clinical trial in 2027 to evaluate psilocybin-assisted therapy for major depressive disorder, potentially advancing psychedelic-bas...

September 10, 2026Read the full article →
SPARC AI Launches Overwatch Patrol to Deliver GPS-Denied Positioning for Dismounted Operations

SPARC AI Launches Overwatch Patrol to Deliver GPS-Denied Positioning for Dismounted Operations

SPARC AI's new Overwatch Patrol application provides continuous location tracking for soldiers and security personnel when GPS is jammed or unavailable, potentially transforming dismounted operations.

September 10, 2026Read the full article →
Coal Prices Surge Globally as Tight Supply Meets Firm Demand

Coal Prices Surge Globally as Tight Supply Meets Firm Demand

Coal prices have risen sharply across major international markets due to supply disruptions and strong demand, with potential benefits for companies holding coal assets.

September 10, 2026Read the full article →
FDA Clears Quantum BioPharma's Lucid-MS for First-in-Human Trial in Multiple Sclerosis

FDA Clears Quantum BioPharma's Lucid-MS for First-in-Human Trial in Multiple Sclerosis

Quantum BioPharma has received FDA clearance to launch a phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis drug designed to shield and potentially rebuild myelin, marking a historic miles...

September 10, 2026Read the full article →
G7 Warns of Quantum Threat to Digital Encryption, Urges Crypto Industry to Prepare

G7 Warns of Quantum Threat to Digital Encryption, Urges Crypto Industry to Prepare

The G7's cybersecurity working group is urging organizations, including the cryptocurrency industry, to prepare for quantum computers that could break current encryption, highlighting the urgent need ...

September 10, 2026Read the full article →
Copper Prices Hit Record High on Looming Trump Tariffs

Copper Prices Hit Record High on Looming Trump Tariffs

Copper prices on the London Metal Exchange reached an all-time high as markets anticipate President Trump expanding tariffs to refined copper imports, raising concerns about demand and market stabilit...

September 10, 2026Read the full article →
Quantum BioPharma Advances Multiple Sclerosis Drug Lucid-MS Toward Phase 2 Trial After FDA Clearance

Quantum BioPharma Advances Multiple Sclerosis Drug Lucid-MS Toward Phase 2 Trial After FDA Clearance

Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor for multiple sclerosis, is moving toward a Phase 2 trial following FDA clearance of its IND application, potentially offering...

September 10, 2026Read the full article →
Building Texas Show
FDA Clears First-in-Class MS Drug for Phase 2 Trial, Targeting Myelin Repair

FDA Clears First-in-Class MS Drug for Phase 2 Trial, Targeting Myelin Repair

Quantum BioPharma has received FDA clearance to launch a phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis treatment designed to shield and potentially rebuild the myelin sheath, a milest...

September 10, 2026Read the full article →
SS Innovations Reports 79% Surge in Robotic Procedures, Expands Global Footprint

SS Innovations Reports 79% Surge in Robotic Procedures, Expands Global Footprint

SS Innovations International announced a 79% increase in procedures using its SSi Mantra surgical robot, along with a 42% growth in installed systems and new international milestones, positioning the ...

September 10, 2026Read the full article →
American Fusion Highlights Texatron Fusion Engine Development and AI Power Strategy in New Interview

American Fusion Highlights Texatron Fusion Engine Development and AI Power Strategy in New Interview

American Fusion Inc. outlined its development of the Texatron Fusion Engine and its strategy to address growing electricity demand from AI and data centers, but acknowledged that key performance miles...

September 10, 2026Read the full article →
Nightfood Holdings Expands AI Robotics Strategy as Labor Shortages Drive Automation Demand

Nightfood Holdings Expands AI Robotics Strategy as Labor Shortages Drive Automation Demand

Nightfood Holdings is expanding its AI robotics strategy through TechForce Robotics to address labor shortages and rising costs with a Robotics-as-a-Service model and a potential 5,000-unit deployment...

September 10, 2026Read the full article →
ESGold Corp. Advances Montauban Gold-Silver Project with Key Equipment Arrival

ESGold Corp. Advances Montauban Gold-Silver Project with Key Equipment Arrival

ESGold Corp. has moved closer to production at its Montauban Gold-Silver Project in Québec with the arrival of critical processing equipment, signaling progress toward anticipated 2026 production.

September 10, 2026Read the full article →
SuperQ Advances Hybrid Quantum Computer to Bridge Enterprise IT Gap

SuperQ Advances Hybrid Quantum Computer to Bridge Enterprise IT Gap

SuperQ Quantum Computing is developing a modular hybrid quantum computer called Super Nova that integrates quantum hardware with classical CPUs and GPUs to overcome adoption barriers, while expanding ...

September 10, 2026Read the full article →
Helus Pharma CEO to Present at Morgan Stanley Healthcare Conference, Highlighting Psychedelic-Inspired Treatments

Helus Pharma CEO to Present at Morgan Stanley Healthcare Conference, Highlighting Psychedelic-Inspired Treatments

Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, drawing attention to the company's novel serotonergic agonists for depression and...

September 10, 2026Read the full article →
Rezolve Ai CEO to Present at H.C. Wainwright Conference, Company Sets October Investor Day

Rezolve Ai CEO to Present at H.C. Wainwright Conference, Company Sets October Investor Day

Rezolve Ai (NASDAQ: RZLV) will participate in the H.C. Wainwright Global Investment Conference and host an Investor Day on October 6 to showcase its agentic commerce business and AI infrastructure.

September 10, 2026Read the full article →
Extend your brand profile by curating daily news.
Onco-Innovations' CMO Highlights Dual-Selectivity Cancer Drug ONC010 in BioMedWire Podcast

Onco-Innovations' CMO Highlights Dual-Selectivity Cancer Drug ONC010 in BioMedWire Podcast

Onco-Innovations' CMO detailed the company's novel PNKP-targeting cancer drug ONC010, which uses synthetic lethality and nanoparticle delivery to potentially offer safer, more effective treatment for ...

September 10, 2026Read the full article →
Lahontan Gold Appoints Billy Choi as CFO, Strengthening Financial Team for Mine Restart

Lahontan Gold Appoints Billy Choi as CFO, Strengthening Financial Team for Mine Restart

Lahontan Gold Corp. has named Billy Choi as its new chief financial officer, a strategic move to bolster financial management as the company advances permitting for the Santa Fe Mine and targets a pro...

September 10, 2026Read the full article →
American Fusion's Texatron Program Advances to Active Testing Phase

American Fusion's Texatron Program Advances to Active Testing Phase

American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak pressures of 100,000 atmospheres and attracting new equity research coverage, signaling potential progres...

September 10, 2026Read the full article →
Quantum BioPharma's Lucid-MS Advances Toward Phase 2 Trial After FDA Clearance

Quantum BioPharma's Lucid-MS Advances Toward Phase 2 Trial After FDA Clearance

Quantum BioPharma's Lucid-MS has received FDA clearance for a Phase 2 trial in multiple sclerosis, marking a significant step for a novel treatment approach that targets demyelination directly rather ...

September 10, 2026Read the full article →